Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ANXA5 M2 Haplotyping in IVF Patients and Embryos

NCT04544462 is registered in ClinicalTrials.gov with Genomic Prediction Inc. as lead sponsor.

NCT NCT04544462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04544462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ANXA5 M2 Haplotyping in IVF Patients and Embryos
Lead sponsor
Genomic Prediction Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
February 10, 2020
Completion date
December 31, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, miscarriage, recurrent, pregnancy complications